Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results Mar 28, 2025 09:03PM
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights Nov 12, 2024 04:05PM
Turnstone Biologics Corp (TSBX) Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte Therapy Nov 5, 2024 09:01AM
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Ann Nov 5, 2024 09:01AM
Turnstone Biologics Corp (TSBX) Announces Strategic Restructuring Oct 11, 2024 06:00AM


Oct 11, 2024 06:00AM Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway